Lista de obras - Bo Dupont - Dominio Público Uruguay

A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy.

artículo científico publicado en 2009

An update to HLA nomenclature, 2010.

artículo científico publicado en 2010

Donor activating KIR2DS1 in leukemia.

artículo científico publicado en 2014

Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2010

Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience

scientific article published on 01 November 2001

Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.

artículo científico publicado en 2003

Genetic interaction among three genomic regions creates distinct contributions to early- and late-onset type 1 diabetes mellitus

article

HLA alleles determine differences in human natural killer cell responsiveness and potency

artículo científico publicado en 2008

HLA class I - associated immunodominance affects CTL responsiveness to an ESO recombinant protein tumor antigen vaccine

artículo científico publicado en 2009

HLA-C–Dependent Prevention of Leukemia Relapse by Donor ActivatingKIR2DS1 ⬇️

artículo científico publicado el 30 de agosto de 2012

Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component

scientific article published on 01 April 2007

Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.

artículo científico publicado en 2005

Introduction: current concepts in immunity to human cancer and therapeutic antitumor vaccines.

artículo científico publicado en 2002

KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.

artículo científico publicado en 2009

KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy

artículo científico publicado en 2006

KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro

artículo científico publicado en 2007

Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets.

artículo científico publicado en 2002

Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis.

artículo científico publicado en 2011

Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.

artículo científico publicado en 2003

Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.

artículo científico publicado en 2003

Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.

artículo científico publicado en 2003

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

artículo científico publicado en 2000

NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand

artículo científico publicado en 2013

Natural killer cell receptors: regulating innate immune responses to hematologic malignancy.

artículo científico publicado en 2005

Nomenclature for factors of the HLA system, 2004

artículo científico publicado en 2005

Nomenclature for factors of the HLA system, 2010

artículo científico publicado en 2010

Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors.

artículo científico publicado en 2002

Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions.

artículo científico publicado en 2001

Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.

artículo científico publicado en 2000

The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry

artículo científico publicado en 2006

The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism.

artículo científico publicado en 2002

Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment

artículo científico publicado en 2012

Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire

artículo científico publicado en 2009

Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients

artículo científico publicado en 2004

Visualization of signaling pathways and cortical cytoskeleton in cytolytic and noncytolytic natural killer cell immune synapses.

artículo científico publicado en 2002

[Killer Ig-like receptor gene content diversity and haplotype analysis in Chinese Han population in Shanghai]

artículo científico publicado en 2003

Lista de obras de Bo Dupont

A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy.

An update to HLA nomenclature, 2010.

Donor activating KIR2DS1 in leukemia.

Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation

Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience

Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.

Genetic interaction among three genomic regions creates distinct contributions to early- and late-onset type 1 diabetes mellitus

HLA alleles determine differences in human natural killer cell responsiveness and potency

HLA class I - associated immunodominance affects CTL responsiveness to an ESO recombinant protein tumor antigen vaccine

HLA-C–Dependent Prevention of Leukemia Relapse by Donor ActivatingKIR2DS1 ⬇️

Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component

Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.

Introduction: current concepts in immunity to human cancer and therapeutic antitumor vaccines.

KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.

KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy

KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro

Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets.

Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis.

Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.

Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.

Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand

Natural killer cell receptors: regulating innate immune responses to hematologic malignancy.

Nomenclature for factors of the HLA system, 2004

Nomenclature for factors of the HLA system, 2010

Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors.

Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions.

Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.

The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry

The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism.

Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment

Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire

Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients

Visualization of signaling pathways and cortical cytoskeleton in cytolytic and noncytolytic natural killer cell immune synapses.

[Killer Ig-like receptor gene content diversity and haplotype analysis in Chinese Han population in Shanghai]